The neurologist’s dilemma: MS is a grey matter disease that standard clinical and MRI measures cannot assess adequately – No

Houshang Amiri, Alexandra de Sitter, Kerstin Bendfeldt, Marco Battaglini, Claudia A. M. Gandini Wheeler‐Kingshott, Massimiliano Calabrese, Jeroen J.G. Geurts, Maria A. Rocca, Jaume Sastre‐Garriga, Christian Enzinger, Nicola De Stefano, Massimo Filippi, Àlex Rovira, Frederik Barkhof, Hugo Vrenken

Article2008

A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes

Antonia Ceccarelli, Maria A. Rocca, Elisabetta Pagani, Bruno Colombo, Vittorio Martinelli, Giancarlo Comi, Massimo Filippi

Article2015

Different MRI Measures Predict Clinical Deterioration AND Cognitive Impairment in MS: A 5 Year Longitudinal Study (P6.142)

Paolo Preziosa, Maria A. Rocca, Šarlota Mesaroš, Massimiliano Copetti, Melissa Petrolini, Jelena Drulović, Elisabetta Pagani, Massimo Filippi